D. Parkin

发表

Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects

H. Kitchener, D. Alexander, J. Mollison, 1996, BMJ.

Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/ progestogen therapy

C. Fletcher, F. al-Azzawi, D. Parkin, 1989, British journal of obstetrics and gynaecology.

A randomised trial comparing local versus general anaesthesia for microwave endometrial ablation

D. Parkin, S. Wallage, K. Cooper, 2003, BJOG : an international journal of obstetrics and gynaecology.

Is outpatient diagnostic hysteroscopy more useful than endometrial biopsy alone for the investigation of abnormal uterine bleeding in unselected premenopausal women?

D. Parkin, C. Bain, K. Cooper, 2002 .

A partially randomized patient preference trial of microwave endometrial ablation using local anaesthesia and intravenous sedation or general anaesthesia: a pilot study

D. Parkin, C. Bain, K. Cooper, 2001 .

TWO-YEAR FOLLOW UP OF WOMEN RANDOMISED TO MEDICAL MANAGEMENT OR TRANSCERVICAL RESECTION OF THE ENDOMETRIUM FOR HEAVY MENSTRUAL LOSS : CLINICAL AND QUA LITY OF LIFE OUTCOMES

A. Garratt, A. Grant, D. Parkin, 1999 .

The performance of screening tests for ovarian cancer: results of a systematic review

D. Parkin, G. Narayansingh, G. Cumming, 1999, British journal of obstetrics and gynaecology.

Profiling Cytochrome P450 Expression in Ovarian Cancer: Identification of Prognostic Markers

Graeme I Murray, G. Murray, M. Cruickshank, 2005, Clinical Cancer Research.

A prospective randomised study of the effects of prophylactic antibiotics on the incidence of bacteraemia following hysteroscopic surgery.

H. Kitchener, J. Mollison, D. Parkin, 1995, European journal of obstetrics, gynecology, and reproductive biology.

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

H. McLeod, N. Haites, G. Murray, 2001, British Journal of Cancer.

Surgical treatment of bleeding problems in perimenopausal women

D. Parkin, C. Bain, S. Dighe, 2005, The journal of the British Menopause Society.

Initial training model for endometrial ablation

D. Parkin, Judith M. Robinson, M. P. Dunkley, 2001 .

Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding

H. Kitchener, D. A. Alexander, A. Naji, 1994, BMJ.

A randomised comparison of microwave endometrial ablation with transcervical resection of the endometrium; follow up at a minimum of five years.

D. Parkin, C. Bain, K. Cooper, 2005, BJOG : an international journal of obstetrics and gynaecology.

Microwave endometrial ablation (MEATM): a safe technique? Complication data from a prospective series of 1400 cases

D. Parkin, 2000 .

A pragmatic randomised comparison of transcervical resection of the endometrium with endometrial laser ablation for the treatment of menorrhagia

H. Kitchener, A. Grant, I. Cameron, 1997, British journal of obstetrics and gynaecology.

A comparison of bladder and ovarian function two years following hysterectomy or endometrial ablation

H. Kitchener, J. Mollison, S. Pinion, 1996, British journal of obstetrics and gynaecology.

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.

D. Cruickshank, S. M. Crawford, S. Kaye, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Definitive chemoradiotherapy for cervical cancer: A 11-year population-based study.

D. Parkin, E. Kalampokas, M. Cairns, 2020, European journal of cancer care.

Use of new imaging techniques to predict tumour response to therapy.

Fiona J Gilbert, F. Gilbert, S. Semple, 2010, The Lancet. Oncology.

Recurrent E pithelial O varian C arcinoma: A R andomized Phase I II S tudy o f P egylated L iposomal D oxorubicin Versus T opotecan

M. Gore, D. Parkin, A. Lacave, 2001 .

Linkage studies with 17q and 18q markers in a breast/ovarian cancer family.

H. Kitchener, D. Cruickshank, N. Haites, 1993, American journal of human genetics.

Is optimal first-line chemotherapy deliverable in all newly diagnosed ovarian cancers? A population-based study

M. Cruickshank, R. Petty, D. Parkin, 2003, British Journal of Cancer.

Urodynamic findings following radiotherapy for cervical carcinoma.

D. Parkin, R. Symonds, J. Davis, 1988, British journal of urology.

Long-term bladder symptomatology following radiotherapy for cervical carcinoma.

D. Parkin, R. Symonds, J. Davis, 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effects of long-term Org OD 14 administration on blood coagulation in climacteric women.

R. Lindsay, D. Parkin, D. Smith, 1987, Maturitas.

Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin

S. Kaye, J. Cassidy, D. Parkin, 1997, Cancer Chemotherapy and Pharmacology.

An Update on the Management of Uterine Carcinosarcoma

D. Parkin, M. Gurumurthy, M. Cairns, 2011, Obstetrical & gynecological survey.

Lipoprotein and apoprotein levels in postmenopausal women during treatment with norethisterone.

C. Fletcher, D. Parkin, E. Farish, 1986, Clinica chimica acta; international journal of clinical chemistry.

Profiling Cytochrome P 450 Expression in Ovarian Cancer : Identification of PrognosticMarkers

G. Murray, M. Cruickshank, I. Miller, 2005 .

Predicting the Response of Advanced Cervical and Ovarian Tumors to Therapy

Fiona J Gilbert, F. Gilbert, D. Parkin, 2009, Obstetrical & gynecological survey.

p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change.

G. Murray, I. Miller, D. Parkin, 1997, Gynecologic oncology.

The genetic causes of the sequential occurrence of multiple primary malignancies in a young woman--5 years on.

N. Haites, D. Parkin, G. Cumming, 2010, European journal of cancer care.

First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.

M. Gore, G. Rustin, H. Gabra, 2010, European journal of cancer.

Current Approaches to the Management of Patients with Endometrial Cancer

N. Vlahos, E. Tsironi, D. Parkin, 2022, Cancers.

Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology Centre.

D. Parkin, E. Kalampokas, M. Gurumurthy, 2018, Anticancer research.

Cerebral metastases from epithelial ovarian carcinoma treated with carboplatin.

H. Kitchener, D. Parkin, K. G. Cooper, 1994, Gynecologic oncology.

A rare case of postmenopausal bleeding due to Wegener's granulomatosis

D. Parkin, P. Ashok, C. Gulliford, 2002, Acta obstetricia et gynecologica Scandinavica.

Bladder function after radical hysterectomy

D. Parkin, R. Symonds, J. Davis, 1989 .

Two-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes.

A. Garratt, A. Grant, D. Parkin, 1999, British journal of obstetrics and gynaecology.

Is This the End of the Line for the Moderate Dyskaryotic Smear?

D. Parkin, V. Harry, G. Narayansingh, 2008, Journal of lower genital tract disease.

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.

D Guthrie, M. Gore, D. Parkin, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer

G. Rustin, P. Vasey, S. Kaye, 2006, British Journal of Cancer.

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

Alan Gordon, James Paul, Gordon C Jayson, 2004, Journal of the National Cancer Institute.

Fatal toxic shock syndrome following endometrial resection

D. Parkin, 1995, British journal of obstetrics and gynaecology.

Magnetic Resonance Imaging in Gynecological Oncology

F. Gilbert, D. Parkin, H. Deans, 2009, International Journal of Gynecologic Cancer.

A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer.

F. Gilbert, S. Semple, D. Parkin, 2009, International journal of radiation oncology, biology, physics.

Uterine leiomyosarcomas: a review of the diagnostic and therapeutic pitfalls

D. Parkin, G. Narayansingh, V. Harry, 2007 .

Endometrial resection and ablation: past, present and future

D. Parkin, 2000 .

Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: a randomised trial

D. Parkin, C. Bain, K. Cooper, 1999, The Lancet.

p53 mutation is a common genetic event in ovarian carcinoma.

H. Kitchener, D. Eccles, N. Haites, 1993, Cancer research.

Endometrial ablation—A review of second generation techniques

D. Parkin, A. Sambrook, 2005 .

Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer.

F. Gilbert, S. Semple, D. Parkin, 2008, Gynecologic oncology.

Gross bilateral haematosalpinges presenting 5 years following endometrial resection

D. Parkin, G. Narayansingh, P. Dillon, 1999 .

Is outpatient diagnostic hysteroscopy more useful than endometrial biopsy alone for the investigation of abnormal uterine bleeding in unselected premenopausal women? A randomised comparison.

D. Parkin, C. Bain, K. Cooper, 2002, BJOG : an international journal of obstetrics and gynaecology.

Diffusion-weighted MRI to detect early response to chemoradiation in cervical cancer: A systematic review and meta-analysis

D. Parkin, V. Harry, Sunil Persad, 2021, Gynecologic oncology reports.

A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss

A. Garratt, A. Grant, D. Parkin, 1997 .

Human papillomavirus 16 infection in adenocarcinoma of the cervix

G. Murray, M. Cruickshank, I. Miller, 2005, British Journal of Cancer.

The significance of p53 mutation and over‐expression in ovarian cancer prognosis

H. Kitchener, D. Eccles, N. Haites, 1996 .

P. Vasey, S. Kaye, J. Graham, 2022 .

A Reappraisal of the Role of Chlorambucil in Patients with End Stage Ovarian Cancer Who Have Previously been Treated with Platinum Regimens

D. Parkin, G. Cumming, T. Sarkar, 2000, Scottish medical journal.

A randomised comparison of microwave endometrial ablation with transcervical resection of the endometrium; follow up at a minimum of five years

D. Parkin, C. Bain, K. Cooper, 2005, BJOG : an international journal of obstetrics and gynaecology.

Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study

Theresa M. Marteau, Nicholas P. J. Day, Linda Sharp, 2009, BMJ : British Medical Journal.

Five‐year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes

A. Grant, D. Parkin, S. Jack, 1999 .

Long‐term incidence of hysterectomy following endometrial resection or endometrial ablation for heavy menstrual bleeding

D. Parkin, E. Kalampokas, F. Payne, 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Magnetic resonance imaging appearances of the uterus following microwave endometrial ablation.

D. Parkin, H. Deans, F. Wallis, 2002, Clinical radiology.

Prognostic factors for success of endometrial ablation and resection

D. Parkin, 1998, The Lancet.

Microwave Endometrial Ablation Versus Endometrial Resection: A Randomized Controlled Trial

D. Parkin, C. Bain, K. Cooper, 2002, Obstetrics and gynecology.

A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss.

A. Garratt, A. Grant, D. Parkin, 1998, British journal of obstetrics and gynaecology.

Blood coagulation profile in long-term hormone replacement therapy with mestranol.

R. Lindsay, F. al-Azzawi, D. Parkin, 1989, Maturitas.

Isolated Clear Cell Adenocarcinoma in Scar Endometriosis Mimicking an Incisional Hernia

D. Parkin, S. Shanbhag, V. Harry, 2007, Obstetrics and gynecology.

Ovarian cancer developing in the ovarian remnant syndrome. A case report and literature review

I. Miller, D. Parkin, G. Narayansingh, 2000, The Australian & New Zealand journal of obstetrics & gynaecology.

Endometrial cancer after endometrial ablation or resection for menorrhagia

D. Parkin, E. Kalampokas, F. Payne, 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Endometrial ablation techniques

D. Parkin, 2000 .

The cost of microwave endometrial ablation under different anaesthetic and clinical settings

D. Parkin, J. Seymour, S. Wallage, 2003, BJOG : an international journal of obstetrics and gynaecology.

Use of a visual analogue scale in the diagnosis of urinary incontinence.

D. Parkin, J. Davis, 1986, British medical journal.

Auditing the Use of Colposcopy Versus General Gynecology Clinics to Investigate Women With Postcoital or Intermenstrual Bleeding: A Case for a New Outpatient Service

M. Cruickshank, D. Parkin, V. Harry, 2007, Journal of lower genital tract disease.

Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation

Fiona J. Gilbert, F. Gilbert, S. Semple, 2012, European Radiology.

Sequential occurrence within three years in a premenopausal woman of cervical, ovarian, and endometrial cancers

N. Haites, D. Parkin, G. Cumming, 2001, Postgraduate medical journal.

A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG).

C. Poole, S. Kaye, J. Graham, 2006, European journal of cancer.

The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva

L. Sharp, M. Cruickshank, I. Miller, 2005, British Journal of Cancer.

Invasive adenocarcinoma of the vagina following surgery for adenocarcinoma in situ of the cervix--recurrence or implantation?

D. Parkin, G. Cumming, S. Dighe, 2001, International Journal of Gynecological Cancer.

Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care

M. Cruickshank, D. Parkin, 2010, BJOG : an international journal of obstetrics and gynaecology.

Vesicovaginal fistula occurring 48 hours after insertion of a ring pessary.

D. Parkin, G. Cumming, G. Narayansingh, 2000, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study

N. Scott, I. Miller, D. Parkin, 2013, Scottish medical journal.

Osseous metaplasia of the endometrium treated by hysteroscopic resection

S. Pinion, D. Parkin, U. Acharya, 1993, British journal of obstetrics and gynaecology.

Two‐year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes

A. Garratt, A. Grant, D. Parkin, 1999, BJOG : an international journal of obstetrics and gynaecology.

A randomised comparison of microwave endometrial ablation with transcervical resection of the endometrium: follow up at a minimum of 10 years

D. Parkin, C. Bain, K. Cooper, 2009, BJOG : an international journal of obstetrics and gynaecology.

Current Approaches to the Management of Patients with Endometrial Cancer

N. Vlahos, E. Tsironi, D. Parkin, 2022, Cancers.

Admission-discharge policies for hysteroscopic surgery: a randomised comparison of day case with in-patient admission.

H. Kitchener, J. Mollison, D. Parkin, 1998, European journal of obstetrics, gynecology, and reproductive biology.